ECSP982595A - Compuestos farmaceuticos - Google Patents

Compuestos farmaceuticos

Info

Publication number
ECSP982595A
ECSP982595A ECSP982595A ECSP982595A EC SP982595 A ECSP982595 A EC SP982595A EC SP982595 A ECSP982595 A EC SP982595A EC SP982595 A ECSP982595 A EC SP982595A
Authority
EC
Ecuador
Prior art keywords
pharmaceutical compounds
4alkoxy
4alkyl
hydrogen
halo
Prior art date
Application number
Other languages
English (en)
Inventor
Peter Thaddeus Gallagher
Martin Victor Miles
John Fairhurst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982595 priority Critical patent/ECSP982595A/es
Publication of ECSP982595A publication Critical patent/ECSP982595A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

El invento se refiere a 1. Un compuesto de la fórmula (gráfico), donde R1 es hidrógeno C1-4 alquil, C1-4 alcoxi o halo,, y R2 es hidrógeno, C1-4 alquil o C1-4 alcoxi; o una sales de los mismos.
ECSP982595 1998-07-16 1998-07-16 Compuestos farmaceuticos ECSP982595A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982595 ECSP982595A (es) 1998-07-16 1998-07-16 Compuestos farmaceuticos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982595 ECSP982595A (es) 1998-07-16 1998-07-16 Compuestos farmaceuticos

Publications (1)

Publication Number Publication Date
ECSP982595A true ECSP982595A (es) 1999-02-11

Family

ID=42043515

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982595 ECSP982595A (es) 1998-07-16 1998-07-16 Compuestos farmaceuticos

Country Status (1)

Country Link
EC (1) ECSP982595A (es)

Similar Documents

Publication Publication Date Title
TR200001876T2 (tr) HIV proteaz inhibitörünün bisülfat tuzu.
MX9203032A (es) Una solucion farmaceutica.
DK0931788T3 (da) Metalloproteasehæmmere
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
TR200200129T2 (tr) Hepatit C inhibitörü tri-peptidler
NO950533L (no) Hydroksyetylaminosulfonamider som er nyttige som retrovirale proteasehemmere
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
NO20013220L (no) Trombin inhibitorer
DK1385515T3 (da) Spiropyrazole forbindelser
DE69812634D1 (de) Metalloproteinase-inhibitoren
NO20002589D0 (no) Bifenylamidinderivater
BR0101230A (pt) Processo para a preparação de11-amino-3-cloro-6,11-diidro-5-5-dioxo-6-metil-dibenzo[c,f][1,2]tiazepina e aplicação para a sìntese detianeptina
EA200000094A1 (ru) Способ получения замещенного пергидроизоиндола
ES2151977T3 (es) Inhibidores de accion doble que contienen 1,2-diazepina.
UY27250A1 (es) Fenil-heterociclil-cteres
SV1998000088A (es) Compuestos farmaceuticos
ECSP982595A (es) Compuestos farmaceuticos
ES2189736T3 (es) Derivados de la benzamida y medicamentos que los contienen.
AR027349A1 (es) Derivados de amidas heterociclicas
DE69827614D1 (de) Chinoxalindionen
DK1097145T3 (da) Polyhydroxyalkylpyrazinderivater, deres fremstilling og lægemidler indeholdende disse derivater
AR026812A1 (es) Empleo de un derivado de fenilurea para la lucha contra la podredumbre tardia de la remolacha
ECSP972052A (es) Quinoxalinadionas
GT199900160A (es) Compuestos plaguicidas de bis-oxima.